Galderma Says Watson Generic Infringes Acne Ointment Patents

Law360, New York (July 30, 2012, 1:24 PM EDT) -- Watson Pharmaceuticals Inc. on Friday was sued in Texas federal court by Swiss skincare treatment company Galderma SA for allegedly seeking to market a knockoff of acne treatment Epiduo that infringes several Galderma patents.

Galderma, which bills itself as “the leading pharmaceutical company devoted entirely to dermatology,” claims Watson is seeking U.S. Food and Drug Administration approval to introduce its own version of the Epiduo acne ointment that infringes a trio of Galderma's patents.

The patents-in-suit are U.S. Patent Numbers 8,071,644 and 8,080,537, both called “Combinations...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.